These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4450862)

  • 1. [Specific prophylaxis of epidemic parotitis with live vaccine (Sofia-6 strain). VI. The epidemiological effectiveness of vaccination].
    Demirov GP; Odiseev KH
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Nov; (11):81-5. PubMed ID: 4450862
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of studying a live mumps vaccine from strain L-3 manufactured by the Moscow Research Institute of Viral Preparations. The epidemiological effectiveness of the vaccine].
    Unanov SS; Bochkov RA; Alekseeva AK; Kaptosova TI; Levchenko EN
    Vopr Virusol; 1977; (1):59-61. PubMed ID: 143795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of mumps in preschool institutions using a live mumps vaccine made from strain L-3].
    Garaseferian MG; Bolotovskiĭ VM; Shatrova LP; Titova NS
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Apr; (4):39-42. PubMed ID: 2970740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunoprophylaxis of epidemic parotitis].
    Shargorodskaia VA
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Sep; 0(9):99-102. PubMed ID: 128272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Specific prevention of epidemic parotitis with live Sofia-6 strain virus].
    Odiseev Kh; Demirov G
    Vopr Virusol; 1972; 17(4):478-9. PubMed ID: 4673662
    [No Abstract]   [Full Text] [Related]  

  • 6. [Expediency and strategy of immunoprophylaxis in epidemic parotitis].
    Sumarokov AA; Salmin LV; Nefedova LA; Khliabich GN; Kamenetskiĭ KM
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Sep; 50(9):14-21. PubMed ID: 4789664
    [No Abstract]   [Full Text] [Related]  

  • 7. [Vaccination against epidemic parotitis].
    Midulla M; Chiavelli S
    Pediatr Med Chir; 1984; 6(1):25-30. PubMed ID: 6442412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficiency of revaccination against epidemic parotitis and immunological safety].
    Iuminova NV; Aleksander SK; Liashchenko VA; Sidorenko ES
    Vopr Virusol; 2002; 47(3):44-5. PubMed ID: 12173437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An intranasal method of revaccination against mumps].
    Krasnova VP; Iuminova NV; Liashenko VA
    Vopr Virusol; 1994; 39(1):24-6. PubMed ID: 8160444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A field trial with live attenuated mumps virus vaccine: a serological study.
    Rossier E; Meunier J; Baker F; Marchessault V
    Can J Microbiol; 1971 Jul; 17(7):929-34. PubMed ID: 5094603
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prospective epidemiologic research on the morbidity with epidemic parotitis, in the Iaşi district, between 1982-2003].
    Melinte L; Manole A; Mitroi I; Duca E
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(4):875-9. PubMed ID: 16004234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccinoprophylaxis of mumps using mumps vaccine, strain Sofia 6, in Bulgaria.
    Odisseev H; Gacheva N
    Vaccine; 1994 Nov; 12(14):1251-4. PubMed ID: 7856287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Safety, antigenic activity, and epidemiologic effectiveness of live mumps vaccine from strain L-3. II. Antigenic activity and epidemiologic effectiveness].
    Brazhdanov NP; Popov VF; Sokhin AA; Salmin LV; Frolov VK
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Feb; (2):45-51. PubMed ID: 7245955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Observation of the effectiveness of active immunization against mumps using a live mumps vaccine].
    Tursunov AKh
    Tr Inst Im Pastera; 1979; 53():55-8. PubMed ID: 162462
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mumps vaccination. Current outlook].
    Chippaux A; Menetrat JL
    Ann Pediatr (Paris); 1984 Jun; 31(6):499-502. PubMed ID: 6465803
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mumps in a urban area of the Community of Madrid. Vaccination status, diagnosis and intervention measures].
    de los Ríos Martín R; García Marín N; Sanz Moreno J; Ballester Orcal E
    Aten Primaria; 2001 Jun; 28(1):10-6. PubMed ID: 11412572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Age distribution of the incidence and immune structure of the pediatric population in epidemic parotitis].
    Lazikova GF; Vardanian NV; Nikolaevskiĭ GP
    Vopr Virusol; 1979; (1):64-6. PubMed ID: 419741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunization of healthy children with mumps-rubella bivalent live vaccine and simultaneous vaccination with mumps-rubella and varicella vaccines].
    Takayama N; Kidokoro M; Suzuki K; Morita M
    Kansenshogaku Zasshi; 1991 Oct; 65(10):1271-5. PubMed ID: 1791323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A field with a liver measles-mumps-rubella vaccine.
    Walters VW; Miller SA; Jackson JE; Kenny MT
    Clin Pediatr (Phila); 1975 Oct; 14(10):928-33. PubMed ID: 1100294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mumps vaccination.
    Hilleman MR
    Mod Trends Med Virol; 1970; 2(0):241-61. PubMed ID: 5527958
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.